Pegcetacoplan (Syfovre™): targeting complement C3 in geographic atrophy

被引：0
|
作者：
Mastellos, Dimitrios C. [1 ]
Lambris, John D. [2 ]
机构：
[1] Natl Ctr Sci Res Demokritos, Athens, Greece
[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2024年 / 45卷 / 12期
关键词：
INHIBITION;
D O I：
10.1016/j.tips.2024.10.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1175 / 1176
页数：2
相关论文
共 50 条
  • [1] Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
    Pfau, Maximilian
    Schmitz-Valckenberg, Steffen
    Ribeiro, Ramiro
    Safaei, Reza
    McKeown, Alex
    Fleckenstein, Monika
    Holz, Frank G.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
    Maximilian Pfau
    Steffen Schmitz-Valckenberg
    Ramiro Ribeiro
    Reza Safaei
    Alex McKeown
    Monika Fleckenstein
    Frank G. Holz
    Scientific Reports, 12
  • [3] Pegcetacoplan (Syfovre) for Geographic Atrophy in Age-Related Macular Degeneration
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1673): : 49 - 50
  • [4] Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan
    Steinle, Nathan C.
    Pearce, Ian
    Mones, Jordi
    Metlapally, Ravi
    Saroj, Namrata
    Hamdani, Mohamed
    Ribeiro, Ramiro
    Rosenfeld, Philip J.
    Lad, Eleonora M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 227 : 116 - 124
  • [5] Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Phase 2 Trial
    Liao, David S.
    Grossi, Federico, V
    El Mehdi, Delphine
    Gerber, Monica R.
    Brown, David M.
    Heier, Jeffrey S.
    Wykoff, Charles C.
    Singerman, Lawrence J.
    Abraham, Prema
    Grassmann, Felix
    Nuernberg, Peter
    Weber, Bernhard H. F.
    Deschatelets, Pascal
    Kim, Robert Y.
    Chung, Carol Y.
    Ribeiro, Ramiro M.
    Hamdani, Mohamed
    Rosenfeld, Philip J.
    Boyer, David S.
    Slakter, Jason S.
    Francois, Cedric G.
    OPHTHALMOLOGY, 2020, 127 (02) : 186 - 195
  • [6] Syfovre Approval for Geographic Atrophy
    Wykoff, Charles C.
    Lad, Eleonora M.
    Heier, Jeffrey S.
    JAMA OPHTHALMOLOGY, 2024, 142 (07) : 685 - 686
  • [7] Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy
    Mancuso, Maria Cristina
    Cugno, Massimo
    Griffini, Samantha
    Grovetti, Elena
    Nittoli, Teresa
    Mastrangelo, Antonio
    Tedesco, Francesco
    Montini, Giovanni
    Ardissino, Gianluigi
    PEDIATRIC NEPHROLOGY, 2025,
  • [8] Concerning Syfovre Approval for Geographic Atrophy
    Schachar, Ira H.
    JAMA OPHTHALMOLOGY, 2024, 142 (02) : 85 - 86
  • [9] Pegcetacoplan in the treatment of geographic atrophy
    Kumar, Madhukar
    Singh, Rishi P.
    IMMUNOTHERAPY, 2023,
  • [10] Syfovre Approval for Geographic Atrophy-Reply
    Schachar, Ira H.
    JAMA OPHTHALMOLOGY, 2024, 142 (07) : 686 - 686
12345